KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Assets Average (2016 - 2025)

Historic Assets Average for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Q3 2025 value amounting to $1.3 billion.

  • Acadia Pharmaceuticals' Assets Average rose 3518.62% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 3518.62%. This contributed to the annual value of $968.4 million for FY2024, which is 4488.02% up from last year.
  • Acadia Pharmaceuticals' Assets Average amounted to $1.3 billion in Q3 2025, which was up 3518.62% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, Acadia Pharmaceuticals' Assets Average ranged from a high of $1.3 billion in Q3 2025 and a low of $595.2 million during Q4 2022
  • Over the past 5 years, Acadia Pharmaceuticals' median Assets Average value was $721.1 million (recorded in 2021), while the average stood at $808.0 million.
  • Per our database at Business Quant, Acadia Pharmaceuticals' Assets Average plummeted by 1639.53% in 2022 and then soared by 5668.7% in 2024.
  • Quarter analysis of 5 years shows Acadia Pharmaceuticals' Assets Average stood at $708.9 million in 2021, then dropped by 16.05% to $595.2 million in 2022, then rose by 16.06% to $690.7 million in 2023, then skyrocketed by 56.69% to $1.1 billion in 2024, then increased by 18.1% to $1.3 billion in 2025.
  • Its Assets Average was $1.3 billion in Q3 2025, compared to $1.2 billion in Q2 2025 and $1.2 billion in Q1 2025.